Should Treatment Differ in African-American and Caucasian Patients?
Should treatment differ in African-Americans and Caucasians? The answer is yes and no. Yes, the choice of initial monotherapy should differ in hypertensive African-Americans and Caucasians. No, the selection and use of antihypertensive drugs should not differ once the patient needs the addition of a second or third drug. No, the compelling clinical indications for specific antihypertensive drug classes do not differ between African-Americans and Caucasians.
KeywordsResistant Hypertension Joint National Committee Goal Blood Pressure Hypertension Optimal Treatment Dietary Salt Intake
Unable to display preview. Download preview PDF.
- 1.Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI) (1997) The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 27: 2413–2446.Google Scholar
- 3.Hall WD, Israili ZI (1995) The use of ACE inhibitors in blacks and whites. In Schacter M, ed. ACE Inhibitors: Current Use and Future Prospects, London: Martin Dunitz pp. 123–143.Google Scholar
- 13.Wright JT Jr (1999) VA First Annual Hypertension Conference. Improvement in the Management of Hypertension in 2000 and Beyond: Challenges and Opportunities. Washington, DC.Google Scholar
- 15.UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 317: 703–713.Google Scholar
- 16.Bakris GL (1999) Renal disease progression. Semin Hypertens Management 2 (1): 12–15.Google Scholar
- 17.Veterans Administration Cooperative Study Group on Antihypertensive Agents (1982) Comparison of propranolol and hydrochlorothiazide for the treatment of hypertension. I. Results on short-term titration with emphasis on racial differences in response. JAMA 248: 1996–2003.Google Scholar
- 18.Veterans Administration Cooperative Study Group on Antihypertensive Agents (1982) Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol 14 (Suppl. 2): 97S - 101S.Google Scholar